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SUMMARY
Clinical pharmacists are specialty trained practitioners 
who provide direct patient care and comprehensive medica-
tion management. While the practice model is most well 
established in the United States, there are clinical phar-
macists throughout the world who are improving the 
care of patients of all ages and in all areas of acute and 
ambulatory care. This paper reviews the training stan-
dards, expected competencies, and contributions of clinical 
pharmacists. 
Key words: Pharmacists, pharmacotherapy, teams, 
residency, training.
INTRODUCTION
Clinical pharmacists are licensed practitioners with 
advanced education and training who practice in all types 
of patient care settings with a focus on comprehensive 
medication management. These specialized pharmacists 
are focused on achieving optimal use of medications, 
emphasizing dosing, monitoring, identification of adverse 
effects, and economic efficiency to achieve optimal patient 
outcomes. Clinical pharmacists are gaining significant atten-
tion worldwide as important members of the patient care 
team for ambulatory and acute care patients. This paper 
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will describe the actual and potential scope of practice of 
clinical pharmacists throughout the world.
DEFINITION OF CLINICAL PHARMACY
The American College of Clinical Pharmacy is the organi-
zation with a primary focus on clinical pharmacist devel-
opment, advancement, and positioning among other 
providers, the public, and professional societies. There 
are over 16,000 members, but many other practitioners 
practice clinical pharmacy. The definition of clinical phar-
macy is a health science discipline where pharmacists 
provide patient care that optimizes medication therapy 
and promotes health, wellness, and disease prevention 
(1). Clinical pharmacists practice in all health care settings 
and utilize in-depth knowledge of medications and disease 
states to manage medication therapy as part of a multi-
professional team. Clinical pharmacists are responsible and 
accountable for medication therapy and patient outcomes. 
They are a primary source of scientifically valid information 
on the safe, appropriate, and cost-effective use of medi-
cations. 
While pharmacists may participate in the management 
of specific medications or individual disease states (e.g. 
diabetes, hypertension) in collaboration with the care team, 
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the goal for clinical pharmacists is a broader approach 
or comprehensive medication management (CMM). The 
definition of CMM is the standard of care that ensures 
each patient’s medications (prescription, non-prescrip-
tion, supplements, or herbals) are individually assessed to 
determine if appropriate for the patient, effective for the 
condition, safe for use with concurrent comorbidities and 
therapies, and that the patient is able to take them. An 
individualized care plan defines the goals, monitoring, and 
intended outcome. The patient is an active participant in 
the development of a CMM plan, along with other members 
of the care team. Key elements of CMM will be described 
in the Standards of Practice Section. The impact of CMM 
provided by clinical pharmacists in ambulatory settings 
is under investigation with a goal to determine effective 
processes and to measure overall patient outcomes. The 
disease-state specific medication therapy management 
programs have shown a reduction in frequency of some 
medication-related problems, including nonadherence, 
and have lowered some healthcare costs (2). 
CLINICAL TEAMS DEFINED 
The American College of Physicians has described the clin-
ical care team in the United States as the health profes-
sionals-physicians, advanced practice registered nurses, 
other registered nurses, physician assistants, clinical phar-
macists, and other health care professionals-with the training 
and skills needed to provide high-quality, coordinated care 
specific to the patient’s clinical needs and circumstances 
(3). Support for team-based practice is also provided by 
the American College of Obstetricians and Gynecologists, 
the Society of Critical Care Medicine, and other organiza-
tions (4). While the composition of teams may vary, the 
responsibility and authority for specific aspects of care 
are optimally assigned to the person most appropriate for 
the task. Optimal team effectiveness relies on a culture of 
trust, shared goals, effective communication and mutual 
respect. The best interests of the patient should be the 
driving force for team activities. All team members need 
not be in a single location and as such the broad group 
of health professionals certainly includes general practice 
pharmacists in hospitals, clinics, and retail settings. 
While just a single example, patients benefit from team-
based care through improved control of BP, and a higher 
proportion of patients achieved controlled BP when a 
pharmacist was part of the team (5).
The composition of dynamic clinical teams is reflected in 
the multi-professional nature of large professional orga-
nizations such as the Society of Critical Care Medicine, 
the Society of Hospital Medicine, the American Society 
of Parenteral and Enteral Nutrition, and the Neurocritical 
Care Society. Most of these organizations include clinical 
pharmacists in governance roles, including the presidency.
PHARMACIST PROCESS OF CARE
Pharmacists in the United States are expected to practice 
in a uniform manner according to the Pharmacist Process 
of Care published in 2015. This process includes multiple 
steps in the medication therapy sequence. The steps are 
illustrated in Figure 1, and include collection of pertinent 
patient care data, assessment of data relative to patient 
goals, development of a patient-centered plan, implemen-
tation of the care plan for therapy and monitoring, and 
reassessment and revision of the plan- all in collaboration 
with the care team (6). However, it is realistic to assume that 
practitioners who were trained many decades ago, and who 
remain in practice are likely to have a different approach to 
direct patient care than the younger pharmacists who have 
been trained this way. However, the POC allows training and 
job descriptions to be focused on a consistent endpoint and 
defines the minimal expected activity for all pharmacists in 
all settings. In medicine, the POC is much more standardized 
and serves as the model for pharmacy.
CLINICAL PHARMACIST STANDARDS OF PRACTICE
Clinical pharmacists are pharmacy the practitioners who 
specialize in direct patient care. While they are expected 
to follow the steps described in the Pharmacist POC, the 
Standards of Practice (SOP) guide the clinical pharmacist 
to comprehensively assess medication related needs, and 
frequently, to manage complex and specialized regimens.
(7) The documentation requirements are more detailed, 
and when applicable must be compatible with billing 
requirements. The clinical pharmacist may practice more 
independently in some settings, especially as defined by 
organizational privileges. Clinical pharmacists who have 
achieved the proper credentials and certification now must 
obtain hospital privileges like physicians and advanced prac-
tice providers. They are required to maintain a valid license, 
but have additional maintenance of certification require-
ments. The clinical pharmacist SOP also includes educational 
activities, scholarly pursuits, and quality improvement.
TRAINING CLINICAL PHARMACISTS
Pharmacy training varies throughout the world. In the 
United States (US), a pharmacist is eligible for licensure 
after 6 years of education and attainment of a Doctor 
of Pharmacy degree. While not required, many of these 
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graduates already have a Bachelor of Science in another 
field. Pharmacists who are interested in direct patient care 
roles can seek additional training in postgraduate year-one 
(PGY-1) residency programs in acute care or ambulatory 
care settings. These are broad-based accredited expe-
riences in clinical care, drug information, administration, 
teaching methods, and project/research over 12 months (8). 
Those interested in specialization can complete a second 
post-graduate year (PGY-2) residency in areas as diverse 
as any medical specialty (ambulatory care, critical care, 
infectious disease, internal medicine, oncology, and many 
others) (9). Additional research fellowship training may 
follow, especially for those interested in an academic or 
research role. 
Pharmacists who are eligible for licensure in the United 
States have completed formal training, and many univer-
sities are partnering with pharmacy schools outside North 
America to create clinical pharmacy training opportunities 
for international students. The training programs in Chile 
have evolved to include additional clinical experiential 
training experiences (10).
Clinical pharmacists may practice under a formal collabo-
rative practice agreement with physicians in their practice 
area or as granted by the hospital (11). As an example, a 
pharmacist may modify the dose, frequency, or route of 
administration of medications covered by a collaborative 
practice agreement. They may also initiate serum concen-
tration monitoring or order other applicable laboratory 
tests to monitor the effects of the therapy. Quality assess-
ment has demonstrated the value of these programs, (12) 
Hospitals may require individuals to provide periodic quality 
assessments or proof of a minimum volume of activity. The 
laws for pharmacist activities are governed by individual 
states and local hospital regulation.
FIGURE 1. THE PHARMACIST PROCESS OF CARE (6)
Ref. 6.
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BOARD CERTIFICATION
Following didactic and experiential training, many clinical 
pharmacists seek Board of Pharmacy Specialties (BPS) 
certification (13). There are more than 21,000 pharmacists 
worldwide who are BPS board certified in eight pharmacy 
specialties: ambulatory care, critical care, nuclear, nutri-
tion support, oncology, pediatric, pharmacotherapy, and 
psychiatric pharmacy. Future specialty certifications may 
include infectious disease and cardiology among others. 
Board certified pharmacists must pass a rigorous examina-
tion and then maintain accreditation through continuing 
education or additional testing every 7 years. Board certi-
fication is a typical requirement to achieve privileges for 
independent or collaborative practice. Aspects of privi-
leging are similar to those used for other medical providers. 
CURRENT ROLES/BENEFITS OF CLINICAL
PHARMACISTS
Clinical pharmacists in the US have established roles in 
many healthcare teams. Most are part of a multiprofes-
sional team for acute care or ambulatory care populations, 
but some have a private practice upon referral from a broad 
population of physicians. There are numerous examples of 
the impact made by clinical pharmacists, and this paper 
will highlight some recent publications (14). 
Since medication management is the primary focus, most 
measurements reflect optimal use of medications and 
avoidance of adverse events. The broad use of antihyper-
tensive medications may lead to adverse outcomes if doses 
are not properly titrated. The benefit of clinical pharmacist 
education, monitoring and intervention was demonstrated 
in a prospective, randomized study of 800 heart failure 
or hypertension patients treated at the clinics of a large 
public hospital (15). The patients with clinical pharmacist 
interventions had a 34% lower risk of any adverse drug 
event (ADE) or medication error (ME) (risk ratio 0.66, 95% 
confidence interval [CI], 0.50-0.88) including a signifi-
cantly lower risk of ADE, preventable ADE, potential ADE, 
and medication errors compared with control patients 
treated at the same clinics. Patients with complicated 
cardiovascular histories had the greatest number of medi-
cations and events. Pharmacist interaction, education, and 
regular communication with the rest of the team improved 
medication adherence, patient satisfaction, and reduced 
healthcare utilization and direct costs of care. A system-
atic review of 12 randomized trials of clinical pharmacist 
impact on heart failure patients showed similar benefits 
with a reduced rate of all-cause hospitalization (Odds ratio 
[OR] 0.71, 95%CI (0.54-0.94) and heart failure hospitaliza-
tion rate OR 0.69, 95%CI (0.51-0.94) (16). Other reviews 
have described additional benefits of clinical pharma-
cist monitoring and interventions on a variety of treat-
ment endpoints (blood pressure, lipid profile, weight, and 
glycemic control) (17). The American College of Cardiology 
has endorsed a strategy of team-based care, including 
clinical pharmacists (18).
Clinical pharmacists on medical inpatient acute care teams 
have been shown to reduce preventable adverse drug 
events by 78% (19). A clinical pharmacist who rounded 
with a critical care team more effectively identified and 
prevented more adverse drug events than pharmacists 
involved in order entry and verification, and avoided the 
potential expenditure of over $210,000 in 4.5 months.
(20) A review of 36 studies describing the impact of 
clinical pharmacists on hospital inpatients suggests that 
the addition of a clinical pharmacist to the acute care 
team resulted in improved care, with no evidence of harm.
(21) Interacting with the team on rounds, interviewing 
patients, reconciling medications from outpatient to 
inpatient, patient discharge education, and follow-up all 
resulted in improved outcomes. Highest risk patients such 
as the very elderly, and the very young have been shown to 
benefit from the presence of and contributions of clinical 
pharmacists.(22,23)
INTERNATIONAL
Clinical pharmacists have increased in number throughout 
the world, and patients have benefited. A survey in 2005 
described critical care clinical pharmacist roles in 24 
countries outside North America (24). The majority 74.4% 
indicated that they attended medical rounds, almost all 
(90%) prospectively reviewed drug therapy and intervened 
to prevent drug interactions, ADE, and to optimize dosing 
and frequency of administration. Pharmacists in Australia 
have described medication therapy interventions for 
hospitalized inpatients and demonstrated their ability to 
reduce length of stay and over $4 million dollars of annu-
alized hospital cost savings in 8 hospitals (25). Over 25% of 
the interventions were major or life-saving. 
Pharmacists in the Netherlands have significantly reduced 
prescribing errors and related patient harm by their pres-
ence on the ward compared with the baseline central 
pharmacy services (26). Pediatric pharmacists in China 
demonstrated a significant reduction in adverse drug 
reactions, length of stay, and drug costs compared with a 
control group of similar patients without a rounding phar-
macist (27). While these illustrate only a few examples, 
there are pharmacists providing patient focused inter-
ventions throughout the world, including Chile. Clinical 
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pharmacy is growing in popularity, and the University of 
Chile offers a training program for pharmacists to become 
Specialists in Clinical Pharmacy and Pharmaceutical Care 
that is more patient and health-team focused and different 
from the academically focused Master in Pharmaceutical 
Science or Doctorate in Pharmacology. 
PHARMACIST COMPETENCY
Statements have been developed to define the basic 
competencies of pharmacists in a number of individual 
countries and also by the International Pharmaceutical 
Federation (28). In Chile, the results of the Pan American 
Conference on Pharmaceutical Education proposal for 
basic education and pharmacist competencies include 
statements that apply to clinical pharmacists- specifi-
cally to document patient information and manage phar-
macotherapy and follow-up (29). Clinical pharmacist or 
advanced and specialist practice competencies have also 
been described and summarized (30). While the United 
States has not compiled a single list of competencies for 
practitioners, a statement describes a general framework 
and there are training criteria for hospital pharmacists 
completing residency training that form the foundation for 
the knowledge and skills expected of a specialist practi-
tioner (31, 32). In the United Kingdom, the National Health 
Service has competency statements for pharmacists and 
also for specialized practitioners (33). This advanced to 
consultant level framework (ACLF) defines level of advanced 
practice (foundation, excellence, and mastery/consultant) 
and the competencies required to practice at each level.
(34) Critical car e pharmacists have developed a peer eval-
uation process and career advancement program that 
has resulted in the credentialing of a growing number of 
practitioners (35). Candidates submit a vida voce and prac-
tice portfolio to provide evidence of their practice model 
based on the ACLF competencies. Supporting references, 
interviews, case-based discussions and peer reviews were 
included in this rigorous process that serves as a model for 
other specialty practices. 
Health systems in many other countries have similarly 
developed pharmacist competency statements.
WHAT I DO AS A CLINICAL PHARMACIST
As a critical care pharmacy specialist, it is difficult to 
describe a typical day, but in general, I am occupied with 
the elements of the pharmacist process of care throughout 
my day. I consider myself to be responsible for all aspects of 
medication management. Each day, I evaluate and assess 
new patients, and update the progress of prior patients, 
identify medication related problems and potential problems, 
develop a problem list and plan of care for optimal dosing based 
on renal and hepatic function, potential drug interactions, and 
serum concentrations. I join multiprofessional rounds with 
the critical care team and ensure implementation of the 
medication plan by coaching medical residents in proper 
order entry or by entering orders myself under a collabo-
rative practice agreement and document in the electronic 
medical record (EMR). A large contribution to medication 
management is to identify therapies that are no longer 
needed, thus reducing cost and risk of adverse events 
and maintaining antimicrobial stewardship programs in 
conjunction with our infectious disease physicians and 
pharmacist. I also monitor for achievement of quality 
measures such as ensuring proper venous thromboembo-
lism prevention, appropriate use of stress gastritis preven-
tion medications, addition of aspirin for troponin elevations 
related to coronary ischemia, and also by discussing need 
for central lines and urinary catheters. I educate the team 
on medication related issues and applicable literature on 
rounds and in didactic discussions. I am always available 
for emergency response and resuscitations and to answer 
mediation-related questions.
For each new patient, a member of the pharmacy team will 
compile a medication history from electronic records, from 
the family, the patient, community physicians or pharma-
cies and document that in the EMR. I will then reconcile that 
list to determine medication-related causes of admission 
such as nonadherence or overdose and provide advice on 
which medications to order to avoid withdrawal reactions 
or other adverse events. While I have a more limited role in 
verifying medication orders within the EMR and almost no 
role in actual drug product dispensing, I serve as a liaison 
with the technicians and pharmacists who are specialists 
in parenteral products and distribution systems to ensure 
that medications are present when needed. Nurses have the 
enormous task of administering medications, and I facilitate 
that process by assisting with intravenous compatibility 
information and education on unfamiliar therapies.
Other aspects of my role include developing quality assess-
ment tools and evaluating data. The EMR is made more 
efficient by proper design of ordering systems that are 
efficient and facilitate achievement of quality measures 
and selection of preferred therapies. I have significant 
input into these ordering systems in the area of medication 
therapy and monitoring. I also report adverse drug events. 
Many adverse events or incidents are related to system-
level problems and I regularly advise on potential process 
improvements in intravenous pumps programming, medi-
cation safety systems or other processes.
[CLINICAL PHARMACISTS: PRACTITIONERS WHO ARE ESSENTIAL MEMBERS OF YOUR CLINICAL CARE TEAM - Judith Jacobi, PharmD]
576
I direct a critical care pharmacist PGY-2 residency 
program and monitor the progress of the resident and 
interactions with other preceptors in our health-system. 
I participate in multiprofessional journal club discussions, 
case conferences and quality review meetings. Like other 
professionals I seek to maintain a role in scholarly contri-
butions to the literature and to maintain competency 
and be current with the burgeoning literature. As a Board 
Certified Critical Care Pharmacist, I have a requirement 
for continuing education and maintenance of certifica-
tion, and as a licensed pharmacist I must also maintain 
continuing education.
FUTURE
While the clinical pharmacy programs are in various stages 
of development globally the need for specialists with a broad 
focus on medications and their optimal use is universal. The 
American College of Clinical Pharmacists has supported 
these training programs and provided education to indi-
viduals and groups. Their publications are used for prepara-
tion and maintenance of board certification by pharmacists 
worldwide. This outreach is expected to continue, as more 
partners are engaged and more pharmacists and their 
multiprofessional teams recognize the opportunities for 
clinical pharmacists to improve patient care. 
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